Skip to main content

Table 1 Baseline characteristics of the subjects stratified by tertiles of quadriceps muscle thickness

From: Quantitative sonographic assessment of quadriceps muscle thickness for fall injury prediction in patients undergoing maintenance hemodialysis: an observational cohort study

Sample characteristics

Quadriceps muscle thickness measured using ultrasonography

P-value

Tertile 1

(n = 60, < 3.66 cm in 42 men and < 3.50 cm in 18 women)

Tertile 2

(n = 60, 3.66–4.59 cm in 43 men and 3.50–4.49 cm in 17 women)

Tertile 3

(n = 60, ≥4.60 cm in 42 men and ≥ 4.50 cm in 18 women)

Age (years)

74 (67–80)*#

67 (65–74)*

66 (50–72)

< 0.001

Duration of dialysis (years)

5.1 (2.3–8.7)

5.4 (2.3–9.7)

6.4 (2.9–11.3)

0.47

Body mass index (kg/m2)

19.9 (18.4–21.7)*#

20.9 (19.8–23.8)*

25.0 (22.1–26.9)

< 0.001

Follow-up period (days)

315 (171–365)*#

365 (348–365)

365 (365–365)

< 0.001

Dialysis prescription

 HD duration of 3.5 h/4.0 h/> 4.0 h, n

1 / 59 / 0

0 / 55 / 5

2 / 45 / 13

< 0.001

 Fluid volume removal (L)

2.2 (1.8–2.8)*

2.4 (1.9–3.0)*

3.0 (2.3–3.3)

< 0.001

Antihypertensive drugs, 0, 1, 2, or 3 or more, n

10 / 20 /11 / 19

14 / 4 / 16 / 26

13 / 5 / 25 / 17

0.032

Benzodiazepine drugs, n (%)

11 (18)

10 (17)

15 (25)

0.80

Any treatments for intradialytic hypotension, n (%)

15 (25)

10 (17)

11 (18)

0.80

Comorbidities

 Diabetes mellitus, n (%)

30 (50)

33 (55)

29 (48)

0.75

 Stroke, n (%)

11 (18)

13 (22)

10 (17)

0.78

 Ischemic heart disease, n (%)

20 (33)

25 (42)

22 (37)

0.64

Serum albumin (g/dl)

3.7 (3.4–3.9)

3.7 (3.6–3.9)

3.8 (3.6–4.0)

0.05

HDL-cholesterol (mg/dl)

43 (36–54)

41 (36–51)

40 (29–53)

0.23

LDL-cholesterol (mg/dl)

77 (59–97)

81 (63–98)

79 (65–102)

0.73

Triglyceride (mg/dl)

71 (58–117)*

92 (65–126)

106 (65–172)

0.012

Uric acid (mg/dl)

6.3 (5.4–7.0)*#

7.0 (5.9–7.9)

7.4 (6.3–8.3)

< 0.001

CRP (mg/dl)

0.09 (0.05–0.38)

0.11 (0.05–0.21)

0.13 (0.05–0.31)

0.88

BUN (mg/dl)

62 (50–74)

64 (55–78)

65 (59–75)

0.40

Creatinine (mg/dl)

9.3 (8.1–10.6)*#

10.8 (9.3–13.1)*

12.4 (10.4–13.8)

< 0.001

Single pool Kt/Vurea

1.46 (1.36–1.61)

1.45 (1.36–1.63)

1.43 (1.31–1.57)

0.36

Ca (mg/dl)

8.7 (8.2–9.1)

8.7 (8.3–9.0)

8.9 (8.5–9.3)

0.08

P (mg/dl)

5.1 (4.2–5.8)#

5.6 (5.1–6.5)

5.5 (4.7–6.2)

0.007

Casual blood glucose, (mg/dl)

135 (112–180)

126 (103–176)

122 (104–149)

0.45

Intact PTH (pg/ml)

136 (80–200)

150 (76–235)

128 (71–183)

0.37

β2 microglobin (mg/l)

25.4 (22.4–28.5)

27.5 (23.9–30.8)

26.7 (22.2–29.2)

0.12

Hemoglobin (g/dl)

11.0 (10.2–11.3)

10.7 (10.3–11.1)

10.8 (10.3–11.5)

0.75

Thigh circumference (cm)

40 (37–42)*#

43 (40–45)*

47 (44–51)

< 0.001

Handgrip strength (kg)

20.8 (16.4–25.2)*#

23.9 (20.6–28.8)

25.3 (21.5–33.0)

< 0.001

  1. Abbreviations: n number; h hours; HDL high-density lipoprotein; LDL low-density lipoprotein; CRP C-reactive protein; BUN blood urea nitrogen; PTH parathyroid hormone
  2. Data are expressed as the median (interquartile range) or number (percentage)
  3. *P < 0.05, compared with tertile 3; #P < 0.05, compared with tertile 2